April 13, 2026

AI Falls Short on Differential Dx

New PrIME-LLM benchmark shows strong diagnostic accuracy but persistent gaps in clinical reasoning across 21 large language models

Conexiant

April 09, 2026

Side Effects: Four Studies Worth Passing On

Kissing celiacs, Ozempic genes, Viagra for the brain, and a UTI test that actually works. This week's evidence is weird, useful, and worth your time.

Conexiant

April 07, 2026

Brief Prehabilitation Reduced Complications Prior to Gastrectomy

Researchers evaluate a supervised, home-based program combining exercise, nutrition, and psychological support before surgery

Conexiant

April 07, 2026

Cancer Is Coming for Younger Adults — and the Field Isn’t Ready

The epidemiological tools built for midlife disease are straining to explain a generational shift

Conexiant

April 07, 2026

Hospital-Treated Infections Linked to Dementia Risk

Investigators identify 29 conditions associated with dementia risk in nationwide registry analysis.

Conexiant

April 06, 2026

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.

Conexiant

April 06, 2026

HS Linked to Higher Cancer Risk

Investigators report site-specific cancer associations and limited adjusted estimates in meta-analysis.

Conexiant

April 03, 2026

Was the GLP-1 Problem Always Cost?

A JAMA Viewpoint argues the BALANCE model targets the leading cause of discontinuation.

Conexiant

April 01, 2026

FDA Approves Lilly’s Foundayo Oral GLP-1 Pill

The newly approved therapy offers a noninjectable option that can be taken at any time of day without food or water restrictions.

Conexiant

March 31, 2026

AHA Updates Heart-Healthy Dietary Guidance

Nine evidence-based features now frame cardiovascular risk reduction across the life course, with sharper language on alcohol, ultraprocessed foods, and plant protein

Conexiant